Edesa Biotech, Inc.
Q3 2024 13F Holders
Symbol
EDSA
CUSIP
27966L306
Type
Equity
Class
COM NEW
Num filings
18
Total reported value, excl. options
$718 k
Compare 2024 Q3 to
2025 Q2
2025 Q1
2024 Q4
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type